Marketplace insurers plan a median premium increase of 15% in 2026 driven by expiration of enhanced premium tax credits and tariff effects on medical costs, per Peterson Center and KFF analysis.

In 2024, US health insurance premiums rose 6% for individuals and 7% for families, with significant state-by-state cost disparities affecting affordability and market dynamics.

Medicare Advantage plans serving 30 million Americans may face cuts or changes due to rising medical utilization and costs. This impacts benefits, networks, and out-of-pocket costs, making the Medicare Annual Election Period critical for plan comparisons.

Texas hospitals reported $329 million in estimated costs for care of undocumented patients from Dec 2024 to Feb 2025, highlighting gaps in payment data and uninsured care context.

S&P Global Ratings warns that proposed Medicaid funding cuts and reimbursement freezes may impact U.S. healthcare providers' financial stability, potentially reducing care access and increasing costs.

Research shows that Medicaid cuts risk severing crucial patient-primary care connections, leading to worse health outcomes and higher costs. Stable insurance ensures preventive care and lowers emergency visits and spending.

Pennsylvania Senate passes Bill 95 with amendment requiring pharmacies to disclose retail and generic drug prices upon consumer request, promoting prescription drug cost transparency and informed purchasing decisions.

Explore the Medicare Part D coverage gap's impact on U.S. retirees, with insights on managing prescription drug costs and navigating supplemental insurance options.

Hospices confront rising operational costs, increased audits, and potential Medicare Advantage coverage changes in 2025, impacting hospice care delivery and financial sustainability.

UnitedHealthcare stops paying commissions on Medicare prescription drug plans sold after June 1, 2025, impacting agents amid rising Medicare Advantage costs and prompting calls for CMS intervention.